04/12/2024
3:34 PM | Immunocore (Filer)
| Form ARS | |
04/05/2024
3:35 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
3:34 PM | Immunocore (Filer)
| Form 424B7 | |
04/02/2024
3:45 PM | Immunocore (Filer)
| Form PRE 14A | |
04/01/2024
11:36 AM | Immunocore (Subject)
St Leger Tina Amber (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
7:51 PM | Immunocore (Filer)
| Form S-3ASR | |
03/20/2024
7:55 PM | Immunocore (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
03/11/2024
7:19 AM | FMR LLC (Filed by)
Immunocore (Subject)
| Form SC 13G | |
03/07/2024
8:45 PM | GENERAL ATLANTIC, L.P. (Filed by)
Immunocore (Subject)
| Form SC 13D/A | |
02/28/2024
3:15 PM | Berman David M (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:19 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
6:33 AM | Immunocore (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/26/2024
5:46 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
3:15 PM | Immunocore (Issuer)
Jallal Bahija (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:15 PM | GOLL JOHN (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:15 PM | Berman David M (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:15 PM | Di Donato Brian (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:16 PM | Immunocore (Issuer)
St Leger Tina Amber (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:57 AM | Immunocore (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/06/2024
10:00 AM | Immunocore (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
02/01/2024
4:25 PM | BAKER BROS. ADVISORS LP (Filed by)
Immunocore (Subject)
| Form SC 13D/A | |
01/05/2024
3:17 PM | Immunocore (Issuer)
St Leger Tina Amber (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
6:19 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
4:55 PM | Immunocore (Subject)
St Leger Tina Amber (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
3:51 PM | Immunocore (Issuer)
Jallal Bahija (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:52 PM | Immunocore (Issuer)
Kaul Siddharth (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:53 PM | Immunocore (Issuer)
PEREZ ROBERT J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:54 PM | Immunocore (Issuer)
Peterson Kristine (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:55 PM | Immunocore (Issuer)
Ratcliffe Peter John (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:57 PM | Immunocore (Issuer)
St Leger Tina Amber (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:41 PM | Di Donato Brian (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:42 PM | Bell John Irving (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:43 PM | Berman David M (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:45 PM | Coy Travis Alan (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:47 PM | GOLL JOHN (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
5:25 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2023
4:30 PM | Immunocore (Subject)
Jallal Bahija (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
12:54 PM | Immunocore (Subject)
St Leger Tina Amber (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/30/2023
7:33 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023
8:51 AM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023
6:09 AM | Immunocore (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Could Your Accounts Be Frozen? (Ad) The US Dollar Is "Finished"
A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments. Get your Free Wealth Protection Kit |
11/06/2023
6:20 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2023
3:31 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023
1:40 PM | GENERAL ATLANTIC, L.P. (Filed by)
Immunocore (Subject)
| Form SC 13D/A | |
08/25/2023
5:10 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/17/2023
2:44 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/10/2023
7:28 AM | Immunocore (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/14/2023
3:21 PM | Immunocore (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2023
4:28 PM | Immunocore (Subject)
Jallal Bahija (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023
4:17 PM | GENERAL ATLANTIC, L.P. (Filed by)
Immunocore (Subject)
| Form SC 13D/A | |
06/05/2023
5:04 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023
8:20 AM | Immunocore (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/10/2023
6:27 AM | Immunocore (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2023
8:29 PM | Immunocore (Subject)
Jallal Bahija (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
